Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
171
currently held
Exits tracked
127
hand-checked
Sectors covered
1
across the portfolio
Countries covered
31
from every market
241 companies matching · Page 2 of 5
Neuraxpharm
CM-CIC Debt Fund 3
GermanySector
Pharma
InvestorCIC Private Debt
Entry
2016
Hold
6yr
Owners
3
Axpharma
FPCI Galiena III
FranceSector
Pharma
InvestorGaliena Capital
Entry
2015
Hold
5yr
Exit
2020
PharmaZell
Europe VI (BE VI)
GermanySector
Pharma
InvestorBridgepoint
Entry
2006
Hold
6yr
Owners
4
Cobra Biologics
Flerie Invest
United KingdomSector
Pharma
InvestorFlerie
Entry
2011
Hold
9yr
Exit
2020
Farma Holding
PCI IV
NorwaySector
Pharma
InvestorProcuritas Capital Investors
Entry
2011
Hold
9yr
Exit
2020
OFI
Alto Capital IV
ItalySector
Pharma
InvestorAlto Partners SGR
Entry
2019
Hold
1yr
Exit
2020
KD Pharma
capiton Omega
GermanySector
Pharma
Investorcapiton
Entry
2013
Hold
7yr
Owners
2
Fagron
Waterland Private Equity Fund VI (WPEF VI)
BelgiumSector
Pharma
InvestorWaterland Private Equity
Entry
2016
Hold
3yr
Exit
2019
Quotient Sciences
Permira VII
UKSector
Pharma
InvestorPermira
Entry
2015
Hold
7yr
Owners
2
Ascelia Pharma
Sunstone Life Science Ventures III
SwedenSector
Pharma
InvestorSunstone Life Science Ventures
Entry
2008
Hold
11yr
Exit
2019
Aurka Pharma, Inc.
TVM Life Science Ventures
Canada
Sector
Pharma
InvestorTVM Capital Life Science
Entry
2016
Hold
3yr
Exit
2019
Lisapharma
Arcadia Small Cap I
ItalySector
Pharma
InvestorArcadia SGR
Entry
2015
Hold
4yr
Exit
2019
Lomapharm
Lenbach Equity Opportunities I
GermanySector
Pharma
InvestorDUBAG Group
Entry
2013
Hold
5yr
Exit
2018
Wilson Therapeutics AB
HealthCap VI
SwedenSector
Pharma
InvestorHealthCap
Entry
2012
Hold
6yr
Exit
2018
Unither Pharmaceuticals
IK Partnership Fund II
FranceSector
Pharma
InvestorIK Partners
Entry
2011
Hold
9yr
Owners
4
EA PHARMA (GROUPE)
Naxicap Legacy Funds
FranceSector
Pharma
InvestorNaxicap Partners
Entry
2006
Hold
11yr
Exit
2017
Generis
Magnum Capital I
PortugalSector
Pharma
InvestorMagnum Capital
Entry
2009
Hold
8yr
Exit
2017
Actelion
Wellington Partners Life Sciences
FranceSector
Pharma
InvestorWellington Partners
Entry
1998
Hold
19yr
Owners
2
Exit
2017
Actelion Holding Ltd
HealthCap (early funds)
SwitzerlandSector
Pharma
InvestorHealthCap
Entry
1997
Hold
20yr
Exit
2017
CoLucid Pharmaceuticals
TVM Life Science Ventures
United StatesSector
Pharma
InvestorTVM Capital Life Science
Entry
2015
Hold
2yr
Exit
2017
Tridem Pharma
Paluel-Marmont Capital Fund
FranceSector
Pharma
InvestorPaluel-Marmont Capital
Entry
2011
Hold
6yr
Exit
2017
Seqens
CM-CIC Debt Fund 3
FranceSector
Pharma
InvestorCIC Private Debt
Entry
2011
Hold
10yr
Owners
6
Italchimici
Progressio Investimenti II
ItalySector
Pharma
InvestorProgressio SGR
Entry
2015
Hold
1yr
Owners
2
Exit
2016
Euticals
Private Equity Partners Fund IV
ItalySector
Pharma
InvestorPrivate Equity Partners
Entry
2008
Hold
4yr
Owners
3
Exit
2016
AB7 HOLDING
SGCP Evergreen (balance sheet)
FranceSector
Pharma
InvestorSociete Generale Capital Partenaires
Entry
2007
Hold
9yr
Exit
2016
ADVANCED ACCELERATOR APPLICATIONS
Naxicap Legacy Funds
FranceSector
Pharma
InvestorNaxicap Partners
Entry
2008
Hold
8yr
Exit
2016
Duopharm
IPDEV 1
Senegal
Sector
Pharma
InvestorInvestisseurs et Partenaires
Entry
2010
Hold
6yr
Exit
2016
Zytoservice
capiton III
GermanySector
Pharma
Investorcapiton
Entry
2008
Hold
8yr
Exit
2016
PHARM’UP
Naxicap Legacy Funds
FranceSector
Pharma
InvestorNaxicap Partners
Entry
2010
Hold
5yr
Exit
2015
Omega Pharma
21 Invest Italy IV
ItalySector
Pharma
Investor21 Invest
Entry
2011
Hold
4yr
Owners
2
AMCo
Cinven Fifth Fund
UKSector
Pharma
InvestorCinven
Entry
2012
Hold
3yr
Exit
2015
OctreoPharm
VC Fonds Technologie Berlin
GermanySector
Pharma
InvestorIBB Ventures
Entry
2011
Hold
4yr
Exit
2015
Tianma Tianji
Mandarin Capital Partners I
China
Sector
Pharma
InvestorMindful Capital Partners
Entry
2010
Hold
5yr
Exit
2015
ACTIVAERO
BayBG Venture Capital
GermanySector
Pharma
InvestorBayBG Bayerische Beteiligungsgesellschaft
Entry
2005
Hold
9yr
Exit
2014
Egalet
Sunstone Life Science Ventures III
DenmarkSector
Pharma
InvestorSunstone Life Science Ventures
Entry
2010
Hold
4yr
Exit
2014
Focus Pharmaceuticals
Mobeus VCTs
UKSector
Pharma
InvestorMobeus Equity Partners
Entry
2001
Hold
13yr
Exit
2014
Nuvisan
ADCURAM Group Holding
GermanySector
Pharma
InvestorADCURAM Group
Entry
2010
Hold
4yr
Exit
2014
TREI
IPEF IV Italy
ItalySector
Pharma
InvestorSynergo Capital SGR
Entry
2004
Hold
10yr
Exit
2014
OctoPlus
FPCI Entreprise & Croissance I
NetherlandsSector
Pharma
InvestorGeneris Capital Partners
Entry
2011
Hold
2yr
Exit
2013
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Nordic Capital (early funds)
United StatesSector
Pharma
InvestorNordic Capital
Entry
2005
Hold
7yr
Exit
2012
Nycomed
Nordic Capital (early funds)
SwitzerlandSector
Pharma
InvestorNordic Capital
Entry
2002
Hold
9yr
Exit
2011
Nycomed Pharma
Nordic Capital (early funds)
SwitzerlandSector
Pharma
InvestorNordic Capital
Entry
2002
Hold
9yr
Exit
2011
Saphar
IPDEV 1
Niger
Sector
Pharma
InvestorInvestisseurs et Partenaires
Entry
2006
Hold
5yr
Exit
2011
PHARMASTER (LABORATOIRES)
Naxicap Legacy Funds
FranceSector
Pharma
InvestorNaxicap Partners
Entry
2003
Hold
7yr
Exit
2010
Bouty Healthcare
Kairos Partners Private Equity Fund
ItalySector
Pharma
InvestorConsilium SGR
Entry
2003
Hold
6yr
Exit
2009
LifeCycle Pharma
Nordic Biotech K/S
DenmarkSector
Pharma
InvestorNordic Biotech Advisors
Entry
2002
Hold
4yr
Exit
2006
Novosis
SHS II
GermanySector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2001
Hold
5yr
Exit
2006
Pharmion Corp.
HealthCap (early funds)
United StatesSector
Pharma
InvestorHealthCap
Entry
2001
Hold
2yr
Exit
2003
Karo Pharma (Karo Bio)
HealthCap (early funds)
SwedenSector
Pharma
InvestorHealthCap
Entry
1996
Hold
2yr
Exit
1998
Piex
LBO France Mid Cap
FranceSector
Pharma
InvestorLBO France
Entry
2017
Hold
9yr
Owners
4